CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-27 | Ganot Ilan Director | Option exercise | +3,883 | 94,807 | ||
| 2024-01-27 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −388 | 777 | ||
| 2024-01-27 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −3,883 | 7,767 | ||
| 2024-01-11 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +904,160 | $5.53 | $5.0M | 4,192,216 |
| 2024-01-11 | PERCEPTIVE ADVISORS LLC Director | Purchase | +3,410,713 | $5.53 | $18.9M | 6,833,539 |
| 2024-01-11 | Bain Capital Life Sciences Investors, LLC Director | Grant or award | +904,160 | $5.53 | $5.0M | 4,034,582 |
| 2024-01-11 | Koppel Adam Director | Grant or award | +904,160 | $5.53 | $5.0M | 4,034,582 |
| 2024-01-09 | Tan Kevin CFO & Treasurer | Option exercise | +11,250 | 13,243 | ||
| 2024-01-09 | Tan Kevin CFO & Treasurer | Sale | −3,935 | $8.20 | $32K | 9,308 |
| 2024-01-09 | Tan Kevin CFO & Treasurer | Option exercise · Restricted Stock Units | −11,250 | 33,750 | ||
| 2024-01-03 | Ganot Ilan Director | Option exercise | +2,993 | 9,309 | ||
| 2024-01-03 | Ganot Ilan Director | Sale | −1,142 | $5.30 | $6K | 8,167 |
| 2024-01-03 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −2,993 | 8,982 | ||
| 2024-01-03 | SMITH IAN F Director | Option exercise | +15,570 | 99,948 | ||
| 2024-01-03 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −15,570 | 0 | ||
| 2024-01-03 | SMITH IAN F Director | Grant or award · Stock Option (Right to Buy) | +15,112 | 15,112 | ||
| 2024-01-03 | SMITH IAN F Director | Grant or award · Restricted Stock Units | +13,021 | 13,021 | ||
| 2023-12-04 | Cumbo Alexander President and CEO | Sale | −11,757 | $2.77 | $33K | 17,439 |
| 2023-12-04 | Howton David T Chief Operating Officer | Sale | −5,367 | $2.78 | $15K | 7,684 |
| 2023-12-04 | Herzich Paul Chief Technology Officer | Sale | −2,968 | $2.77 | $8K | 4,270 |
Page 14 of 21 · 403 trades